(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Xeris Pharmaceuticals is 2152640
Date | Daily Closing Price | Open | High | Low | Volume |
30 Mon Jun 2025 | 4.67 | 4.71 | 4.90 | 4.65 | 1.403 times |
27 Fri Jun 2025 | 4.70 | 4.72 | 4.74 | 4.59 | 2.177 times |
26 Thu Jun 2025 | 4.74 | 4.71 | 4.76 | 4.65 | 0.617 times |
25 Wed Jun 2025 | 4.71 | 4.66 | 4.77 | 4.56 | 0.524 times |
24 Tue Jun 2025 | 4.66 | 4.67 | 4.73 | 4.55 | 0.736 times |
23 Mon Jun 2025 | 4.64 | 4.44 | 4.64 | 4.40 | 0.75 times |
20 Fri Jun 2025 | 4.51 | 4.64 | 4.69 | 4.48 | 1.455 times |
18 Wed Jun 2025 | 4.58 | 4.54 | 4.71 | 4.45 | 0.873 times |
17 Tue Jun 2025 | 4.54 | 4.48 | 4.79 | 4.44 | 1.523 times |
13 Fri Jun 2025 | 4.35 | 4.34 | 4.41 | 4.30 | 0.826 times |
My analysis of stock is bullish for shortterm, and stock might move up till 4.8 or till 5. Use a stoploss of 4.6 and if this stock hits its stoploss, then it can fall down till 4.43
Share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Target | 3.45 |
Downside Target | 3.59 |
Downside Target | 3.81 |
Downside Target | 4.10 |
Downside Target | 4.26 |
Downside Target | 4.40 |
Downside Target | 4.65 |
Upside Target | 4.77 |
Upside Target | 4.90 |
Upside Target | 5.11 |
Upside Target | 5.28 |
Upside Target | 5.50 |
Upside Target | 5.97 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Intraday Target | 4.58 |
Downside Intraday Target | 4.49 |
Upside Intraday Target | 4.83 |
Upside Intraday Target | 4.99 |
Upside Intraday Target | 4.74 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Mon Jun 2025 | 4.67 | 4.71 | 4.90 | 4.65 | 0.292 times |
27 Fri Jun 2025 | 4.70 | 4.44 | 4.77 | 4.40 | 1.247 times |
20 Fri Jun 2025 | 4.51 | 4.48 | 4.79 | 4.44 | 0.949 times |
13 Fri Jun 2025 | 4.35 | 4.58 | 4.65 | 4.30 | 0.581 times |
06 Fri Jun 2025 | 4.58 | 5.00 | 5.11 | 4.31 | 2.267 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Mon Jun 2025 | 4.67 | 5.00 | 5.11 | 4.30 | 1.012 times |
30 Fri May 2025 | 4.94 | 4.58 | 5.28 | 4.26 | 0.769 times |
30 Wed Apr 2025 | 4.57 | 5.48 | 5.50 | 3.81 | 0.738 times |
31 Mon Mar 2025 | 5.49 | 3.85 | 5.97 | 3.59 | 2.305 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Xeris Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.61 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Xeris Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.61 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.